Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
PUT
BlackLine
BL
$1.84B
| $4.03M | ﹤0.01% |
+60,000
| New | +$4.14M |
|
|
TSVT
1677
DELISTED
2seventy bio
TSVT
| $4.02M | ﹤0.01% |
394,126
+317,124
| +412% | +$3.63M |
|
|
AAT
1678
American Assets Trust
AAT
$1.45B
| $4.02M | ﹤0.01% |
216,033
-13,798
| -6% | -$336K |
|
1679
CALL
Blackrock
BLK
$169B
| $4.01M | ﹤0.01% |
6,000
-6,000
| -50% | -$4.23M |
|
|
SF
1680
Stifel
SF
$12.6B
| $3.99M | ﹤0.01% |
101,355
-27,627
| -21% | -$1.16M |
|
1681
PUT
Conagra Brands
CAG
$6.94B
| $3.99M | ﹤0.01% |
106,300
-27,300
| -20% | -$1.01M |
|
1682
Medpace
MEDP
$16.1B
| $3.99M | ﹤0.01% |
21,197
+1,565
| +8% | +$324K |
|
1683
Strategy Inc
MSTR
$34.1B
| $3.96M | ﹤0.01% |
135,580
-266,450
| -66% | -$6.5M |
|
1684
Telefônica Brasil
VIV
$20.6B
| $3.95M | ﹤0.01% |
522,400
-740
| -0.1% | -$5.56K |
|
1685
LCI Industries
LCII
$2.49B
| $3.95M | ﹤0.01% |
35,948
+4,206
| +13% | +$460K |
|
|
SGI
1686
CALL
Somnigroup International
SGI
$13.7B
| $3.95M | ﹤0.01% |
100,000
-284,100
| -74% | -$11.3M |
|
|
PGRE
1687
DELISTED
Paramount Group
PGRE
| $3.95M | ﹤0.01% |
865,187
-121,827
| -12% | -$669K |
|
1688
Tetra Tech
TTEK
$8.49B
| $3.94M | ﹤0.01% |
134,170
+24,545
| +22% | +$709K |
|
1689
Hilton Grand Vacations
HGV
$3.59B
| $3.94M | ﹤0.01% |
88,714
+18,547
| +26% | +$840K |
|
1690
Harley-Davidson
HOG
$2.58B
| $3.94M | ﹤0.01% |
103,733
-112,847
| -52% | -$4.96M |
|
1691
PUT
Peloton Interactive
PTON
$2.77B
| $3.93M | ﹤0.01% |
346,600
+114,600
| +49% | +$1.38M |
|
1692
AbCellera Biologics
ABCL
$1.74B
| $3.92M | ﹤0.01% |
520,521
+203,493
| +64% | +$1.85M |
|
1693
Celldex Therapeutics
CLDX
$2.99B
| $3.92M | ﹤0.01% |
109,024
-7,447
| -6% | -$321K |
|
|
PDM
1694
Piedmont Realty Trust
PDM
$1.21B
| $3.92M | ﹤0.01% |
536,891
+62,432
| +13% | +$573K |
|
|
RXDX
1695
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.92M | ﹤0.01% |
36,510
-10,222
| -22% | -$1.18M |
|
1696
CALL
Gilead Sciences
GILD
$162B
| $3.92M | ﹤0.01% |
47,200
-163,200
| -78% | -$13.5M |
|
|
HCMAW
1697
DELISTED
HCM Acquisition Corp Warrant
HCMAW
| $3.92M | ﹤0.01% |
375,000
| – | – |
|
1698
Wheaton Precious Metals
WPM
$49.5B
| $3.91M | ﹤0.01% |
81,243
+8,686
| +12% | +$380K |
|
1699
New York Times
NYT
$12.1B
| $3.91M | ﹤0.01% |
100,574
-22,958
| -19% | -$846K |
|
1700
Workiva
WK
$3.36B
| $3.89M | ﹤0.01% |
37,992
+10,315
| +37% | +$935K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.